Aipu Co., Ltd.: Completed the acquisition of 80% equity in Noah Shengnuo.

Aipu Co., Ltd. announced that the company has established a wholly-owned subsidiary, Aipu Life Technology, which will acquire 100% of the equity of Noah San Biotechnology held by Noah San Europe for 450 million yuan, via two transactions. The first transaction involves the acquisition of 80% of the equity, while the second transaction will transfer the remaining 20% after the performance commitment period expires. On June 22, 2026, both parties signed the transfer agreement and supplementary agreement. On August 13, Aipu Life Technology completed the delivery and acceptance for the first transaction, acquiring 80% of the equity in the target company. After the transaction is completed, there may be risks such as poor synergy between the two parties, and the company will promptly disclose further progress.